Logo     Print Page  Close Window


News, Events & Presentations


Press Releases | Events Calendar | Presentations

Keyword Search
 
2017 | 2016 | 2015 | 2014
DateTitle 
03/10/17Fibrocell Announces One-for-Three Reverse Stock SplitPrinter Friendly Version
03/09/17Fibrocell Reports 2016 Financial Results and Recent Operational HighlightsPrinter Friendly Version
03/07/17Fibrocell to Host Conference Call and Webcast on Thursday, March 9, 2017 to Discuss 2016 Financial Results and Recent Operational HighlightsPrinter Friendly Version
03/07/17Fibrocell Announces Convertible Preferred Stock Financing for $8.0 MillionPrinter Friendly Version
02/23/17Fibrocell Announces Dosing of First Patient in Phase I/II Clinical Trial of FCX-007 Gene Therapy for Treatment of Recessive Dystrophic Epidermolysis BullosaPrinter Friendly Version
01/05/17Fibrocell Announces FDA Fast Track Designation of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis BullosaPrinter Friendly Version